Literature DB >> 33136442

Electronic Cigarettes and Vaping-Associated Lung Injury (EVALI): A Rural Appalachian Experience.

Rahul Sangani1, Edward Rojas1, Michael Forte1, Rafia Zulfikar1, Nicole Prince2,3, Antonios Tasoglou4, Travis Goldsmith5, Gary Casuccio4, Jonathan Boyd3,5,6,7, I Mark Olfert5,7,8, Melina Flanagan9, Sunil Sharma1.   

Abstract

Background: Electronic cigarette use has increased dramatically since their introduction in 2007. Respiratory complications, particularly lipoid pneumonia, have been reported as early as 2012. An outbreak of pulmonary injury in 2019 has been reported in patients using vaping products.Research Question: To describe a rural Appalachian tertiary center's experience of EVALI and to identify novel mechanisms of pulmonary injury patterns.Study Design and
Methods: We present a consecutive case series of 17 patients admitted to our rural, academic, tertiary care institution with EVALI from August 2019 to March 2020. Demographics, baseline characteristics, co-morbidities, vaping behavior, and hospital course were recorded. Broncho-alveolar lavage specimens were assessed for lipid-laden macrophages and hemosiderin-laden macrophages with stains for Oil-Red-O (n = 15) and Prussian Blue (n = 14) respectively.The patient volunteered e-liquid materials (n = 6), and vapors were analyzed using a proton transfer reaction time-of-flight mass spectrometer (PTR-TOF-MS) to describe the chemical profile. Post-discharge interviews were conducted.
Results: The most common CT finding was bilateral ground-glass opacities with a predilection for lower lung zones. The most frequent pulmonary injury pattern was lipoid pneumonia. The majority of EVALI patients were critically ill requiring ventilation or ECMO. The most severely ill patients were noted to be positive for iron stains in macrophages and showed higher volatile organic compound (VOC) levels in chemical analysis.Interpretation: Based on our experience, EVALI in rural Appalachia presented with relatively severe respiratory failure. Worse outcomes appear to be correlated to high levels of VOCs, iron deposition in lungs, and concomitant infection.

Entities:  

Keywords:  Electronic Cigarettes and Vaping-Associated Lung Injury (EVALI); iron; lipoid pneumonia; rural Appalachian region; volatile organic compounds

Mesh:

Year:  2021        PMID: 33136442      PMCID: PMC8371980          DOI: 10.1080/21548331.2020.1843282

Source DB:  PubMed          Journal:  Hosp Pract (1995)        ISSN: 2154-8331


  28 in total

1.  An unexpected consequence of electronic cigarette use.

Authors:  Lindsay McCauley; Catherine Markin; Danielle Hosmer
Journal:  Chest       Date:  2012-04       Impact factor: 9.410

2.  Pathology of Vaping-Associated Lung Injury.

Authors:  Yasmeen M Butt; Maxwell L Smith; Henry D Tazelaar; Laszlo T Vaszar; Karen L Swanson; Matthew J Cecchini; Jennifer M Boland; Melanie C Bois; James H Boyum; Adam T Froemming; Andras Khoor; Isabel Mira-Avendano; Aiyub Patel; Brandon T Larsen
Journal:  N Engl J Med       Date:  2019-10-02       Impact factor: 91.245

3.  Anti-inflammatory effects of linalool on ovalbumin-induced pulmonary inflammation.

Authors:  Min-Gu Kim; Seong-Man Kim; Jae-Hong Min; Ok-Kyoung Kwon; Mi-Hyeong Park; Ji-Won Park; Hye In Ahn; Jeong-Yeon Hwang; Sei-Raying Oh; Jae-Won Lee; Kyung-Seop Ahn
Journal:  Int Immunopharmacol       Date:  2019-06-26       Impact factor: 4.932

4.  Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Final Report.

Authors:  Jennifer E Layden; Isaac Ghinai; Ian Pray; Anne Kimball; Mark Layer; Mark W Tenforde; Livia Navon; Brooke Hoots; Phillip P Salvatore; Megan Elderbrook; Thomas Haupt; Jeffrey Kanne; Megan T Patel; Lori Saathoff-Huber; Brian A King; Josh G Schier; Christina A Mikosz; Jonathan Meiman
Journal:  N Engl J Med       Date:  2019-09-06       Impact factor: 91.245

5.  Linalool reverses neuropathological and behavioral impairments in old triple transgenic Alzheimer's mice.

Authors:  Angélica Maria Sabogal-Guáqueta; Edison Osorio; Gloria Patricia Cardona-Gómez
Journal:  Neuropharmacology       Date:  2015-11-06       Impact factor: 5.250

6.  Nicotine, aerosol particles, carbonyls and volatile organic compounds in tobacco- and menthol-flavored e-cigarettes.

Authors:  Mi-Sun Lee; Ryan F LeBouf; Youn-Suk Son; Petros Koutrakis; David C Christiani
Journal:  Environ Health       Date:  2017-04-27       Impact factor: 5.984

7.  Association Between Youth Smoking, Electronic Cigarette Use, and COVID-19.

Authors:  Shivani Mathur Gaiha; Jing Cheng; Bonnie Halpern-Felsher
Journal:  J Adolesc Health       Date:  2020-08-11       Impact factor: 5.012

Review 8.  Iron Homeostasis in the Lungs-A Balance between Health and Disease.

Authors:  Joana Neves; Thomas Haider; Max Gassmann; Martina U Muckenthaler
Journal:  Pharmaceuticals (Basel)       Date:  2019-01-01

9.  Update: Characteristics of Patients in a National Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injuries - United States, October 2019.

Authors:  Erin D Moritz; Lauren B Zapata; Akaki Lekiachvili; Emily Glidden; Francis B Annor; Angela K Werner; Emily N Ussery; Michelle M Hughes; Anne Kimball; Carla L DeSisto; Brandon Kenemer; Mays Shamout; Macarena C Garcia; Sarah Reagan-Steiner; Emily E Petersen; Emily H Koumans; Matthew D Ritchey; Brian A King; Christopher M Jones; Peter A Briss; Lisa Delaney; Anita Patel; Kara D Polen; Katie Sives; Dana Meaney-Delman; Kevin Chatham-Stephens
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-11-01       Impact factor: 17.586

10.  The EVALI outbreak and vaping in the COVID-19 era.

Authors: 
Journal:  Lancet Respir Med       Date:  2020-08-14       Impact factor: 30.700

View more
  1 in total

Review 1.  Vaping-Associated Lung Injury: A Review.

Authors:  Marissa O'Callaghan; Niamh Boyle; Aurelie Fabre; Michael P Keane; Cormac McCarthy
Journal:  Medicina (Kaunas)       Date:  2022-03-10       Impact factor: 2.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.